LBBW raises target for Gerresheimer stock from EUR 28 to EUR 29

Published on 10/12/2026 at 09:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 adjusted EBITDA rose to EUR 102.00 million from EUR 67.00 million. Gerresheimer stock was EUR 28.41 versus EUR 28.66 Xetra close on October 12, 2026.

Key points in brief

LBBW raised its Gerresheimer price target from EUR 28.00 to EUR 29.00 while retaining a Hold rating on October 6, 2026.
Gerresheimer reported Q2 2026 adjusted EBITDA of EUR 102.00 million, up from EUR 67.00 million in Q1.
The stock was EUR 28.41 at Lang & Schwarz on October 12, 2026, minus 0.87 percent versus the Xetra close of October 9, 2026.
The final first-half 2026 report is scheduled for November 2026, followed by a Berenberg conference on December 2, 2026.

Isometrische Grafik der Wertschöpfungskette der Pharmaglasherstellung — Gerresheimer AG, ISIN DE000A0LD6E6, veranschaulicht in isometrischer Grafik die gesamte Wertschöpfungskette der Pharmaglasherstellung übersichtlich, Illustration mit AI erstellt.

Gerresheimer stock stood at EUR 28.41 at Lang & Schwarz on October 12, 2026 at 9:13 a.m. CEST, minus 0.87 percent versus the Xetra close of October 9, 2026 at EUR 28.66. On October 6, 2026, Goldesel reported that LBBW raised its price target from EUR 28.00 to EUR 29.00 and retained a Hold rating.

Three milestones shape the recovery

On September 30, 2026, Gerresheimer reported Q2 2026 revenue of EUR 578.00 million and adjusted EBITDA of EUR 102.00 million, up EUR 35.00 million from Q1. On October 1, 2026, EQS Group reported the completed Centor sale and the planned use of proceeds for debt reduction. The LBBW target change followed on October 6, 2026.

What does the margin say?

The operating rebound is visible quarter on quarter, but the annual comparison remains weaker. Gerresheimer's Q2 2026 adjusted EBITDA margin reached 17.60 percent, while adjusted EBITDA remained below the EUR 126.00 million reported for Q2 2025, according to Gerresheimer. The company expects a stronger second half of 2026, while the full-year outlook calls for organic revenue in the lower half of a EUR 2.30 billion to EUR 2.40 billion range and an adjusted EBITDA margin of 17.00 percent to 18.00 percent, according to Investing.com.

Dates point to execution risk

The next two scheduled milestones are the final first-half 2026 report in November 2026 and the Berenberg European Conference on December 2, 2026, listed on Gerresheimer's investor-relations page. The second divestment, Primary Packaging Plastics, is targeted for the first half of 2027. That timetable makes debt reduction and delivery of the stronger second-half earnings profile the central tests behind the cautious Hold rating.

Stock stays below the yearly high

The EUR 28.41 Lang & Schwarz price is 11.22 percent below the EUR 32.00 52-week high and sits within the EUR 14.83 to EUR 32.00 range dated October 9, 2026. LBBW's EUR 29.00 target is 2.08 percent above the Lang & Schwarz price, leaving a limited numerical gap rather than signaling a broad change in stance.

Gerresheimer stock price and outlook

At Lang & Schwarz, Gerresheimer was trading at EUR 28.41 on October 12, 2026 at 9:13 a.m. CEST, minus 0.87 percent versus the Xetra close of October 9, 2026 at EUR 28.66. The further course of trading is shown by the continuously updated real-time quote of Gerresheimer stock.